In contrast, low expression of NEDD4L (OS: HR = 0.75, RFS: HR = 0.59, PPS: HR = 0.53) and SELENBP1 (OS: HR = 0.65, RFS: HR = 0.56, PPS: HR = 0.64) was associated with poor prognosis, suggesting a protective role by inhibiting tumor progression. This evidence concerns the gene SELENBP1 and neoplasm.